Apogee Therapeutics, Inc.
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| – | – | – | – | |
| – | – | – | +650.3% | |
| – | +184.9% | +282.3% | +98.3% | |
| – | -37.8% | -132.8% | – | |
| – | – | +589.8% | +346.8% | |
| – | – | +9.7% | -40.2% | |
| – | +87.4% | +57.0% | -19.9% | |
| – | -121.9% | – | -144.9% | |
| – | – | – | – |
Data as of: September 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.